[1]
Liu Y,Liu S,Liu L,Gong X,Liu J,Sun L,Liu X,Wu L,Chen L,Wang L,Luo L,Lin J,Tie N,Jiang Z,Wu J,Lu F,Sun H,Li X,Yang N,Chai K,Wei H,Da Z,Zhao C,Dai L,Wang Y,Shi G,Zhang Z,Song H,Guo Q,Liu YC,Li Z, Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study. Rheumatology and therapy. 2021 Nov 22 [PubMed PMID: 34806155]
[2]
Lahad A,Weiss B, Current therapy of pediatric Crohn's disease. World journal of gastrointestinal pathophysiology. 2015 May 15; [PubMed PMID: 25977836]
[3]
Pola S,Patel D,Ramamoorthy S,McLemore E,Fahmy M,Rivera-Nieves J,Chang JT,Evans E,Docherty M,Talamini M,Sandborn WJ, Strategies for the care of adults hospitalized for active ulcerative colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2012 Dec; [PubMed PMID: 22835577]
[4]
Infliximab therapy in pediatric patients 7 years of age and younger., Kelsen JR,Grossman AB,Pauly-Hubbard H,Gupta K,Baldassano RN,Mamula P,, Journal of pediatric gastroenterology and nutrition, 2014 Dec [PubMed PMID: 25419596]
[5]
Maini R,St Clair EW,Breedveld F,Furst D,Kalden J,Weisman M,Smolen J,Emery P,Harriman G,Feldmann M,Lipsky P, Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet (London, England). 1999 Dec 4 [PubMed PMID: 10622295]
[6]
Akiho H,Yokoyama A,Abe S,Nakazono Y,Murakami M,Otsuka Y,Fukawa K,Esaki M,Niina Y,Ogino H, Promising biological therapies for ulcerative colitis: A review of the literature. World journal of gastrointestinal pathophysiology. 2015 Nov 15 [PubMed PMID: 26600980]
[7]
Scott FI,Lichtenstein GR, Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease. Current treatment options in gastroenterology. 2014 Mar; [PubMed PMID: 24452768]
[8]
You Y,Stelzl P,Joseph DN,Aldo PB,Maxwell AJ,Dekel N,Liao A,Whirledge S,Mor G, TNF-α Regulated Endometrial Stroma Secretome Promotes Trophoblast Invasion. Frontiers in immunology. 2021; [PubMed PMID: 34790194]
[9]
Jiang Y,Lin O,Sinha SR, Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure. Digestive diseases and sciences. 2017 Jun; [PubMed PMID: 28417241]
[10]
Lichtenstein L,Ron Y,Kivity S,Ben-Horin S,Israeli E,Fraser GM,Dotan I,Chowers Y,Confino-Cohen R,Weiss B, Infliximab-Related Infusion Reactions: Systematic Review. Journal of Crohn's [PubMed PMID: 26092578]
[11]
Li J,Zhang Z,Wu X,Zhou J,Meng D,Zhu P, Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis. Frontiers in pharmacology. 2021; [PubMed PMID: 34790122]
[12]
Djokanovic N,Klieger-Grossmann C,Pupco A,Koren G, Safety of infliximab use during pregnancy. Reproductive toxicology (Elmsford, N.Y.). 2011 Jul [PubMed PMID: 21621603]
[13]
Penagini F,Cococcioni L,Pozzi E,Dilillo D,Rendo G,Mantegazza C,Zuccotti GV, Biological therapy in pediatric age. Pharmacological research. 2020 Nov [PubMed PMID: 32783974]
[14]
Lee CK, [Ideal vaccination strategy in inflammatory bowel disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2015 Mar [PubMed PMID: 25797379]